Results
1
-
6
of
6
Interferon-Free Hepatitis C Therapy
,
Drugs
BMS halts development of Hep C drug after death of patient
,
Reactions Weekly
Idenex Pharmaceuticals, Inc. have had a clinical hold placed by the US FDA on IDX-19368,
,
Reactions Weekly
Interferon-Free Hepatitis C Therapy
,
Drugs
[DOI: 10.2165/11635560-000000000-00000]
BMS halts development of Hep C drug after death of patient
,
Reactions Weekly
[DOI: 10.2165/00128415-201214170-00003]
Idenex Pharmaceuticals, Inc. have had a clinical hold placed by the US FDA on IDX-19368,
,
Reactions Weekly
[DOI: 10.2165/00128415-201214180-00009]